Efficacious End User Measures—Part 1 : Relative Class Size and End User Problem Domains

Abstract EN

Biological and medical endeavors are beginning to realize the benefits of artificial intelligence and machine learning.

However, classification, prediction, and diagnostic (CPD) errors can cause significant losses, even loss of life.

Hence, end users are best served when they have performance information relevant to their needs, this paper’s focus.

Relative class size (rCS) is commonly recognized as a confounding factor in CPD evaluation.

Unfortunately, rCS-invariant measures are not easily mapped to end user conditions.

We determine a cause of rCS invariance, joint probability table (JPT) normalization.

JPT normalization means that more end user efficacious measures can be used without sacrificing invariance.

An important revelation is that without data normalization, the Matthews correlation coefficient (MCC) and information coefficient (IC) are not relative class size invariants; this is a potential source of confusion, as we found not all reports using MCC or IC normalize their data.

We derive MCC rCS-invariant expression.

JPT normalization can be extended to allow JPT rCS to be set to any desired value (JPT tuning).

This makes sensitivity analysis feasible, a benefit to both applied researchers and practitioners (end users).

We apply our findings to two published CPD studies to illustrate how end users benefit.